baber/WOPTO huggingface dataset:
Patent CA-3001040-A1 (CA)
Inventor: GROSSMAN ROBERT L
IPC: G06F21/50
Filed: 2017-06-02
Abstract: A cybersecurity system for managing cyber behavior associated with cyber actors such that the cyber behavior can be computed and predicted and cyber interactions between the cyber actors can be created. The system includes a cyber behavioral space management module configured to receive input data, and data from the interaction engine and the analytic workflow engine, and to generate a plurality of cyber behavioral spaces based on the received data. The system includes an interaction engine configured to process cyber actor data to facilitate interactions with the cyber behavioral space, a cyber scene, a cyber map, and another cyber actor. The system includes an analytic workflow engine configured to analyze the cyber behavioral spaces and update cyber data based on the analyzed data and the interaction engine data. The system includes a visualization engine configured to compute visualizations and transmit the visualizations for display.
Patent CA-3002761-A1 (CA)
Inventor: NEWBOLD PAUL
IPC: A61K39/395
Filed: 2016-11-03
Abstract: The present disclosure relates to the use of protein and/or gene expression levels of dipeptidyl peptidase-4 (DPP4/CD26) and periostin (POSTN) as peripheral biomarkers for eosinophilic diseases or disorders, e.g., moderate to severe asthma. Levels of the DPP4 and/or POSTN above or below predetermined DPP4 or POSTN threshold levels can be used, e.g., (i) to determine a patient's eligibility for a certain treatment with an IL-5R antagonist, e.g., an anti-IL- 5R antibody such as benralizumab (MEDI-563), (ii) to determine whether a certain treatment of an eosinophilic disease or disorder with a specific IL-5R antagonist should commence, be suspended, or be modified, (iii) to diagnose whether an eosinophilic disease or disorder is treatable or not treatable with a specific IL-5R antagonist, (iv) to prognosticate the outcome of treating an eosinophilic disease or disorder with a specific IL-5R antagonist, etc.
Patent CA-3003496-A1 (CA)
Title: Articles optiques et leur procede de preparation
Inventor: KUMAR ANIL
IPC: G02B5/23
Filed: 2015-10-30
Abstract: L'invention concerne un article optique qui comprend un élément optique et une couche de revêtement anisotrope formée sur au moins une partie de l'élément optique. La couche de revêtement anisotrope peut comprendre une première zone d'influence lumineuse comprenant au moins un premier matériau anisotrope et une seconde zone d'influence lumineuse comprenant au moins un second matériau anisotrope. Au moins une desdites première zone d'influence lumineuse et seconde zone d'influence lumineuse comprennent en outre au moins un matériau dichroïque et/ou au moins un matériau photochrome dichroïque de telle sorte que la première zone d'influence lumineuse et la seconde zone d'influence lumineuse présentent une propriété de couleur différente, un changement réversible photochrome dichroïque différent, une quantité différente de polarisation, ou une combinaison de ces derniers.
Patent CA-3004259-A1 (CA)
Title: Medical protocol evaluation
Inventor: STANKIEWICZ BRIAN J
IPC: G16B45/00
Filed: 2016-10-27
Abstract: A computer-implemented method of evaluating a plurality of protocols associated with a medical context includes receiving, with a computer system, an indication of a medical context item corresponding to a medical context, accessing, with the computer system, a digital library including a plurality of protocols associated with the medical context, assigning, with the computer system, predictive outcomes to one or more of plurality of protocols, selecting, with the computer system, one of the plurality of protocols associated with the medical context based upon the assigned predictive outcomes, and storing, with the computer system within a database, an indication the selected protocol is assigned to the medical context item.
Patent CA-3008471-A1 (CA)
Inventor: PAN KAI
IPC: A61K47/34
Filed: 2016-12-06
Abstract: The present invention relates to an apremilast sustained release preparation. Specifically, the present invention relates to an apremilast composition which is a sustained release preparation having a high bioavailability in the body. The present invention provides a sustained release drug preparation containing an apremilast sustained release component and a site-specific release component therefor. Within in vitro release testing, the release speed is steady and constant.
Patent CA-3008538-A1 (CA)
Title: Modular power washer system, method and kit therefor
Inventor: RICKEY TODD
IPC: B05B15/00
Filed: 2016-02-22
Abstract: A modular power washer contains a power washing system (10), containing a base unit (20) and an accessory unit (34), wherein the accessory unit (34) is removably-attached to the base unit (20). The base unit (20), contains a housing (22), a pump (26), a motor (24), a power source (28), an input valve (64), and an output valve (32). The housing (22), contains the pump (26), and the motor (24), therein, and the housing (22), at least partially contains the power source (28), therein. The motor (24), is operatively-connected to the power source (28). The pump (26), is operatively-connected to the motor (24). The pump (26), is fluidly-connected to the input valve (64), and the output valve (32). The accessory unit (34), is selected from a hose storage unit (68), an additive tank ( 88), a handle (36) a roll bar (50), a frame (72), a wheel (74), and a combination thereof. A kit and a method of use are also described herein.
Patent CA-3010692-A1 (CA)
Title: Plaque frontale dans des afficheurs a projection optique transparents
Inventor: HOLMER ANNA-KARIN
IPC: G02B27/01
Filed: 2016-01-05
Abstract: La présente invention concerne des dispositifs et un procédé de surveillance d'une image d'affichage (2) dans un afficheur à projection optique transparent. Ils concernent un moniteur d'image d'affichage (1) comprenant une plaque frontale à fibres optiques (4) et un capteur d'image (5). La plaque frontale à fibres optiques (4) comprend une première surface (4a) ayant des extrémités de fibre optique et une seconde surface (4b) ayant des extrémités de fibre optique correspondantes et transférant la lumière de la première surface (4a) à la seconde surface (4b) par les fibres optiques, la première surface venant en butée contre une partie (2a) de l'image d'affichage (2) au niveau d'un plan image focalisée (2b) et ainsi la lumière de la partie de l'image d'affichage entre par les extrémités des fibres optiques et la seconde surface étant conçue pour diriger la partie de l'image d'affichage vers le capteur d'image, ce qui permet de transférer la partie de l'image d'affichage au capteur d'image.
Patent CA-3012942-A1 (CA)
Inventor: GLINER VADIM
IPC: A61B34/20
Filed: 2018-07-31
Abstract: Catheterization is carried out by inserting a probe having a location sensor into a body cavity, and in response to multiple location measurements identifying respective mapped regions of the body cavity. Using the location measurements, a simulated 3-dimensional surface of the body cavity is constructed. One or more unmapped regions are delineated by rotating the simulated 3-dimensional surface about an axis. The simulated 3-dimensional surface of the body cavity is configured to indicate locations of the unmapped regions based on the location measurements.
Patent CA-3015003-A1 (CA)
Inventor: EBERLEIN MARTIN
IPC: B62B3/14
Filed: 2017-03-02
Abstract: The invention relates to a transporting device (1) that can be moved by hand and stacked in stacks of identical devices, comprising a first carrying device (4) and comprising a second carrying device (8) arranged above the first carrying device (4), wherein the first carrying device (4), viewed from above, is designed to be wider than the second carrying device (8), wherein, in addition, the first carrying device (4) has a first fixing means (6) each arranged in the rear area of the carrying device and on both sides, and wherein a handle device (13) for moving the carrying device (1) is fixed to each first fixing means (6). The second carrying device (8) has a second fixing means (10) each arranged in the rear area (12) of the carrying device and on both sides, wherein each handle device (13) is additionally fixed to the nearest of the two second fixing means (10), and wherein between the two handle devices there is formed an interspace (18), which is used by the second carrying device (8) of a rear transporting device (1) when the latter is pushed into a transporting device (1) located in front.
Patent CA-3017012-A1 (CA)
Title: Energy transfer machine and method
Inventor: KLASSEN JAMES B
IPC: F03G7/06
Filed: 2008-06-18
Abstract: A novel engine for producing power from a temperature differential with additional benefits of low cost, high efficiency, quiet operation minimal wear of components, and the ability to produce power or cooling from low grade heat sources.
Patent CA-3017391-A1 (CA)
Inventor: ISMERT DOMINIC P
IPC: E03B7/12
Filed: 2018-09-14
Abstract: A two-part sillcock includes interior and exterior sillcock members selectively coupled to actuate a valve that controls fluid flow to a faucet. The interior sillcock member includes a flanged housing having an inlet, an outlet, and a valve with a stem including a coupling at the outlet end. The coupling is supported within the housing by an adapter adjacent the outlet end. The exterior sillcock member includes a flanged faucet including a handle shaft with a coupling at the inlet end. An adapter adjacent the housing outlet supports the valve stem coupling and guides and receives the faucet handle shaft coupling for engagement of the couplings. When the exterior and interior sillcock flanges are connected, the faucet handle shaft coupling is connected with the valve stem coupling, so that movement of the handle controls operation of the valve. A dual two-part sillcock includes two sillcocks connected by a mixing assembly.
Patent CA-3019167-A1 (CA)
Inventor: NORTON PIERCE O
IPC: G01N21/03
Filed: 2017-03-28
Abstract: Aspects of the present disclosure include a particle sorting module for sorting components of a sample, such as cells in a biological sample. Particle sorting modules according to certain embodiments include an enclosed housing having an aligner for coupling the housing with a particle sorting system, a flow cell nozzle positioned at the proximal end of the housing, a sample interrogation region in fluid communication with the orifice of the flow cell nozzle and a droplet deflector. A particle sorting system and methods for separating components of a sample as well as kits, including one or more particle sorting module, suitable for coupling with a particle sorting system and for practicing the subject methods are also provided.
Patent CA-3021214-A1 (CA)
Title: Modular circuit board for telecommunications system
Inventor: PALLONE FRANK CARLO
IPC: H04B1/40
Filed: 2018-10-17
Abstract: A modular circuit board for use in a telecommunications network may comprise a plurality of modules, each module operable as an independent circuit board and capable of communicating with a device and a central controller for processing information and distributing workload across the plurality of modules. Each module of the plurality of modules may be interchangeable, removeable, and/or customizable.
Patent CA-3022577-A1 (CA)
Inventor: VELEZ DE MENDIZABAL ALONSO IKER
IPC: F41H5/04
Filed: 2018-10-29
Abstract: Modular mould for producing a panel comprising a layer (10) of fibre reinforced material, the layer (10) configured to form hollow cells (3) comprising an undulated trapezoidal cross-section, characterised in that the mould comprises at least three moulding bars for forming each hollow cell (3), one moulding bar (4) having a trapezoidal cross shape and two moulding bars (5) having a triangular cross shape, the trapezoidal moulding bar (4) configured to be located in between the two triangular moulding bars (5) and the three moulding bars (4, 5) being configured such that when put together its cross-section forms the shape of the trapezoidal cross- section of the hollow cell (3).
Patent CA-3027673-A1 (CA)
Inventor: HANDFIELD MARTIN
IPC: A01N63/50
Filed: 2017-07-14
Abstract: The disclosure relates to lantibiotic structural variants that have improved antimicrobial properties when compared to wild-type lantibiotics, and uses thereof. Embodiments include non- naturally occurring lantibiotics.
Patent CA-3027678-A1 (CA)
Inventor: LAPOINTE LARRY P
IPC: A47C1/032
Filed: 2017-07-26
Abstract: A furniture member may include a base frame and a seat assembly mounted on the base frame. The seat assembly may include a seat frame, a seatback, a seat bottom, a rocker member, a legrest mechanism, and a tilt mechanism. The rocker member is attached to the seat frame and rollingly contacts the base frame. The rocker member supports the seat assembly relative to the base frame such that the seat assembly is movable between a rocked-back tilt position and a rocked-forward tilt position. The legrest mechanism is mounted to the seat frame and attached to a legrest platform. The legrest mechanism may include a drive rod coupled to a pantograph linkage that is movable relative to the seat frame between retracted and extended positions. The tilt mechanism selectively locks the seat assembly in one of an infinite number of tilt positions between the rocked-back and rocked-forward tilt positions.
Patent CA-3027847-A1 (CA)
Inventor: YANG YONG
IPC: B23H9/14
Filed: 2017-05-05
Abstract: A system is configured for machining a workpiece (100), the workpiece includes an interior surface (110) that defines an internal passage (112). The system includes an electrode (116) located within the internal passage and electrically isolated from the workpiece, an electrolyte supply, a power supply, and a remover. The electrolyte supply is configured for circulating an electrolyte in a gap between the electrode and the workpiece. The power supply is configured for applying a voltage between the electrode and the workpiece to facilitate smoothing the interior surface. The remover is configured for completely removing the electrode from within the internal passage after smoothing the interior surface.
Patent CA-3030056-A1 (CA)
Inventor: RALF BUCK RALF
IPC: E04G1/20
Filed: 2017-07-17
Abstract: L'invention concerne une structure échafaudage de service à agencer à l'intérieur d'une tour, en particulier à l'intérieur d'une tour d'éolienne et un module de structure échafaudage pour une telle structure échafaudage ainsi qu'une tour équipée d'une telle structure échafaudage de service et une éolienne dotée d'une tour équipée d'une telle structure échafaudage de service. L'invention concerne en outre un procédé pour ériger et/ou faire fonctionner une structure échafaudage de service et un procédé pour ériger une tour. La structure échafaudage de service comprend plusieurs modules de structure échafaudage superposés et interconnectés, un premier module de structure échafaudage étant réalisé sous forme de module de sol lorsque la structure échafaudage de service est en fonction, ledit module de sol étant disposé debout sur un sol, en particulier un sol de la tour ou une plateforme de base de la tour et un autre module de structure échafaudage étant réalisé sous forme de module central qui est disposé sur le module de sol.
Patent CA-3031061-A1 (CA)
Title: Reconstitution device for iv fluids and method of use
Inventor: TRIBBLE Dennis Anthony
IPC: A61J1/14
Filed: 2017-06-27
Abstract: A system is provided for storage and reconstitution of IV solutions. The system may include one or more storage and reconstitution devices each configured to store and manipulate IV solution containers containing IV solutions in crystalline form that include hydration chemicals and therapeutic drugs. Crystalline hydration chemicals may include crystalline salts and sugars. The containers may be dimensionally precise enough for mechanical manipulation and configured such that sharp objects such as needles are not needed for fluid delivery to or from the container. Each storage and reconstitution device may store stacked containers and may include components for retrieval of a container from the storage and for reconstitution of the contents therein using a sterile water source within the device. IV doses may be manufactured, under appropriate standards, that can be mechanically reconstituted to produce high-quality doses in real time on the patient care unit or in the pharmacy.
Patent CA-3031978-A1 (CA)
Title: A method of isolating mesenchymal stem cells from umbilical cord amniotic membrane using a cell culture medium
Inventor: PHAN TOAN THANG
IPC: A61K35/51
Filed: 2017-10-05
Abstract: The present invention relates to a method of isolating a mesenchymal stem cell population from the amniotic membrane of the umbilical cord, the method comprising cultivating umbilical cord tissue in a culture medium comprising DMEM (Dulbecco's modified eagle medium), F12 (Ham's F12 Medium), M171 (Medium 171) and FBS (Fetal Bovine Serum). The invention also relates to a mesenchymal stem population isolated from the amniotic membrane of the umbilical cord, wherein at least about 90 % or more cells of the stem cell population express each of the following markers: CD73, CD90 and CD105 and lack expression of the following markers: CD34, CD45 and HLA-DR. The invention also relates to a pharmaceutical composition of this mesenchymal stem population.
Patent CA-3033035-A1 (CA)
Title: Methode de diagnostic de pancreatite aigue (ap) par detection d'isoforme alpha de glycoproteine 2 (gp2a)
Inventor: ROGGENBUCK DIRK
IPC: G01N33/68
Filed: 2017-09-26
Abstract: L'invention concerne une méthode in vitro de diagnostic de pancréatite aiguë (AP) chez un sujet par détection d'une protéine d'isoforme alpha de glycoprotéine 2 (GP2a). En particulier, l'invention concerne une méthode in vitro de diagnostic de pancréatite aiguë (AP) chez un sujet par détection d'une protéine d'isoforme alpha de glycoprotéine 2 (GP2a), consistant à utiliser un échantillon d'un sujet humain présentant des symptômes de maladie pancréatique, ledit échantillon étant obtenu à partir du sujet dans les 72 heures après l'apparition desdits symptômes, à utiliser un réactif d'affinité dirigé contre la GP2a, à mettre en contact ledit échantillon avec ledit réactif d'affinité, ce qui permet de capturer la GP2a dudit échantillon, et à déterminer la concentration de GP2a dudit échantillon. Selon l'invention, une détermination d'une concentration de GP2a dans ledit échantillon supérieure à la concentration moyenne de GP2a dans des échantillons témoins, tels que d'un groupe d'individus sains, indique la présence d'AP et l'absence d'une ou de plusieurs maladies parmi la pancréatite chronique, le cancer du pancréas, le cancer gastro-intestinal, le cancer du foie, la tumeur neuroendocrinienne, le sarcome, l'ulcère gastroduodénal ou la péritonite. L'invention concerne en outre un kit et un système développés pour la mise en uvre de la méthode revendiquée et la détermination de la concentration de GP2a de même que pour la mise en uvre d'une analyse automatisée d'un ou de plusieurs échantillons.
Patent CA-3033188-A1 (CA)
Title: Tissue specific markers for preoperative and intraoperative localization and visualization of tissue
Inventor: DALMA-WEISZHAUSZ Dennise
IPC: C12Q1/68
Filed: 2017-08-11
Abstract: Surgeons may face the difficulty of preoperatively selecting the location for making an incision and intraoperatively identifying and differentiating targeted tissue for removal or for identification so that it is not removed along with neighboring or non-target tissue or so that neighboring or non-target tissue is not nicked, harmed, or removed accidentally. A tissue specific marker can include an aptamer or an affimer configured to bind to a pre-selected target tissue and one or more indicator elements coupled with the aptamer or the affimer. The one or more indicator elements produce a signal thereby allowing identification of the target tissue in a preoperative and operative manner.
Patent CA-3033232-A1 (CA)
Inventor: ALAGIA NICOLA ANTONIO
IPC: A61M5/315
Filed: 2017-08-04
Abstract: Des dispositifs d'administration de médicaments, des systèmes de détection et des procédés sont décrits pour déterminer les mouvements axiaux et rotatifs relatifs de ses éléments afin de déterminer la quantité d'un ensemble de doses définies et/ou délivrée par le dispositif d'administration de médicaments. Un système de détection comprend un système de détection de canon (100), un système de détection de manchon d'entraînement (130) et/ou un système de détection axial (140). Le système de détection de canon (100) est destiné à détecter la position angulaire relative absolue du cylindre par rapport au boîtier pendant le réglage de dose. Le système de détection de manchon d'entraînement (130) est destiné à détecter la position angulaire relative absolue du manchon d'entraînement par rapport au boîtier pendant l'administration de la dose. Le système de détection axiale (140) est destiné à détecter les positions axiales relatives du cadran de dose par rapport au boîtier pendant le réglage et l'administration de la dose. Un contrôleur reçoit les sorties des systèmes de détections correspondant aux positions relatives absolues pour déterminer les quantités réelles d'ensembles de doses définies et de doses délivrées.
Patent CA-3037692-A1 (CA)
Inventor: SOARES DA SILVA PATRICIO
IPC: A61K31/4188
Filed: 2017-09-22
Abstract: This invention relates to: (a) compounds of formula (I) (with R1 to R5, n and A as defined herein) and pharmaceutically acceptable salts or solvates thereof that are useful as dopamine-ß-hydroxylase inhibitors; (b) pharmaceutical compositions comprising such compounds, salts or solvates; (c) the use of such compounds, salts or solvates in therapy; (d) therapeutic methods of treatment using such compounds, salts or solvates; and (e) processes and intermediates useful for the synthesis of such compounds.
Patent CA-3039918-A1 (CA)
Title: New derivatives of indole for the treatment of endometriosis
Inventor: POULETTY PHILIPPE
IPC: C07D209/18
Filed: 2017-10-23
Abstract: The present invention relates to compounds of formula (I) and pharmaceutical compositions comprising such compounds, for use for treating and/or preventing endometriosis.
Patent CA-3041269-A1 (CA)
Title: Automated teller machine(atm) device with sealed slot
Inventor: FALETTI STEVE
IPC: G07F19/00
Filed: 2019-04-25
Abstract: A device may include a first slot on a front portion of the device, and a security bar in an interior of the device. The security bar may comprise a second slot. The device may be configured to rotate the security bar to align the first slot and the second slot. Alignment of the first slot and the second slot may facilitate a transfer between the interior of the device and an exterior of the device.
Patent CA-3045597-A1 (CA)
Inventor: YANG SEUNGRYUL
IPC: H04N21/236
Filed: 2017-07-06
Abstract: A broadcast signal transmitting method is disclosed. The broadcast signal transmitting method comprises the steps of: processing at least one component of a broadcast service on the basis of a delivery protocol; generating service layer signaling (SLS) information including information on the component; generating service list table (SLT) information including bootstrap information for acquiring the SLS information; and generating a signal frame including a physical layer pipe (PLP) by performing a physical layer processing on the at least one component, the SLS information and the SLT information.